Labeler
Aurobindo Pharma Limited NDC Codes
Aurobindo Pharma Limited lists 827 finished drug products in the FDA NDC Directory under NDC labeler codes 59651, 84386.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Brivaracetam, Bupropion Hydrochloride, Amitriptyline Hydrochloride, Eslicarbazepine Acetate, Dapagliflozin and Metformin hydrochloride, everolimus, Cyclosporine, Isotretinoin, Tofacitinib, Pirfenidone, Cinacalcet, Bisoprolol Fumarate and Hydrochlorothiazide, Deferasirox, Tizanidine, vancomycin hydrochloride
- Active ingredients
- Brivaracetam, Dapagliflozin, Bupropion hydrochloride, Amitriptyline hydrochloride, Eslicarbazepine acetate, Metformin hydrochloride, Everolimus, Cyclosporine, Isotretinoin, Tofacitinib citrate, Pirfenidone, Potassium chloride
- NDC labeler codes
- 59651, 84386
- Strengths (from the 100 most recently listed products)
- Dapagliflozin 5 mg/1; Dapagliflozin 10 mg/1; Hydrochlorothiazide 6.25 mg/1; Bupropion hydrochloride 150 mg/1; Pirfenidone 267 mg/1; Metformin hydrochloride 500 mg/1; Metformin hydrochloride 1000 mg/1; Cyclosporine 25 mg/1; Cyclosporine 50 mg/1; Cyclosporine 100 mg/1; Isotretinoin 20 mg/1; Isotretinoin 30 mg/1; Isotretinoin 40 mg/1; Tizanidine hydrochloride 2 mg/1; Tizanidine hydrochloride 4 mg/1; Brivaracetam 10 mg/mL; Eslicarbazepine acetate 200 mg/1; Eslicarbazepine acetate 400 mg/1; Eslicarbazepine acetate 600 mg/1; Eslicarbazepine acetate 800 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Tablet, Film coated, Extended release, Capsule, Solution, Capsule, Liquid filled, Gel, Powder, For suspension, Cream, Granule, Kit, Powder, For solution, Tablet, Orally disintegrating, Tablet, Extended release, Liquid, Granule, For solution, Suspension
- Routes
- Oral, Topical
- Drug classes (FDA established)
- Osmotic Laxative, Tricyclic Antidepressant, Nonsteroidal Anti-inflammatory Drug, Sodium-Glucose Cotransporter 2 Inhibitor, Aminoketone, Retinoid, Biguanide, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Calcineurin Inhibitor Immunosuppressant, Cephalosporin Antibacterial, Janus Kinase Inhibitor, Pyridone, Potassium Salt, Calcium-sensing Receptor Agonist, Serotonin Reuptake Inhibitor, Thiazide Diuretic, beta-Adrenergic Blocker, Iron Chelator, Central alpha-2 Adrenergic Agonist, Atypical Antipsychotic, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Phenothiazine, Histamine-2 Receptor Antagonist, Carbonic Anhydrase Inhibitor, alpha-Adrenergic Blocker, Endothelin Receptor Antagonist, Opioid Agonist, Nitrogen Binding Agent, Lincosamide Antibacterial, Azole Antifungal, Corticosteroid, Angiotensin Converting Enzyme Inhibitor, gamma-Aminobutyric Acid-ergic Agonist, Amide Local Anesthetic, Antiarrhythmic, Loop Diuretic, Nitroimidazole Antimicrobial, Phenylalanine Hydroxylase Activator, Direct Thrombin Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 165 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Metformin Hydrochloride | Metformin hydrochloride 500 mg/1 | Tablet, Extended releaseOral | 59651-042 | 59651-0042-60 | — |
| Metformin Hydrochloride | Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | 59651-043 | 59651-0043-60 | — |
| Metronidazole | Metronidazole 10 mg/g | GelTopical | 59651-813 | 59651-0813-60 | — |
| nitrofurantoin (macrocrystals) | Nitrofurantoin 25 mg/1 | CapsuleOral | 59651-942 | 59651-0942-01 | — |
| Cephalexin | Cephalexin 250 mg/1 | Tablet, Film coatedOral | 59651-783 | 59651-0783-01 | — |
| Cephalexin | Cephalexin 500 mg/1 | Tablet, Film coatedOral | 59651-784 | 59651-0784-01 | — |
| Mycophenolate Mofetil | Mycophenolate mofetil 200 mg/mL | Powder, For suspensionOral | 59651-646 | 59651-0646-26 | — |
| Estradiol Vaginal Insertsestradiol | Estradiol hemihydrate 10 ug/1 | Tablet, Film coatedVaginal | 59651-439 | 59651-0439-0859651-0439-18 | — |
| Dutasteride and Tamsulosin Hydrochloride | Dutasteride .5 mg/1; Tamsulosin hydrochloride .4 mg/1 | CapsuleOral | 59651-063 | 59651-0063-3059651-0063-90 | — |
| Posaconazole | Posaconazole 100 mg/1 | Tablet, Delayed releaseOral | 59651-596 | 59651-0596-60 | — |
| Levothyroxine Sodium | Levothyroxine sodium 137 ug/1 | TabletOral | 59651-554 | 59651-0554-9059651-0554-99 | — |
| Levothyroxine Sodium | Levothyroxine sodium 150 ug/1 | TabletOral | 59651-555 | 59651-0555-9059651-0555-99 | — |
| Levothyroxine Sodium | Levothyroxine sodium 175 ug/1 | TabletOral | 59651-556 | 59651-0556-9059651-0556-99 | — |
| Levothyroxine Sodium | Levothyroxine sodium 200 ug/1 | TabletOral | 59651-557 | 59651-0557-9059651-0557-99 | — |
| Levothyroxine Sodium | Levothyroxine sodium 300 ug/1 | TabletOral | 59651-558 | 59651-0558-9059651-0558-99 | — |
| Lidocaine | Lidocaine 50 mg/g | OintmentTopical | 59651-591 | 59651-0591-3059651-0591-3559651-0591-50 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 6 mg/mL | Powder, For suspensionOral | 59651-597 | 59651-0597-60 | — |
| Bupropion Hydrochloride | Bupropion hydrochloride 75 mg/1 | Tablet, Film coatedOral | 59651-874 | 59651-0874-01 | — |
| Bupropion Hydrochloride | Bupropion hydrochloride 100 mg/1 | Tablet, Film coatedOral | 59651-875 | 59651-0875-01 | — |
| Haloperidol | Haloperidol .5 mg/1 | TabletOral | 59651-789 | 59651-0789-0159651-0789-99 | — |
| Haloperidol | Haloperidol 1 mg/1 | TabletOral | 59651-790 | 59651-0790-0159651-0790-99 | — |
| Haloperidol | Haloperidol 2 mg/1 | TabletOral | 59651-791 | 59651-0791-0159651-0791-99 | — |
| Haloperidol | Haloperidol 5 mg/1 | TabletOral | 59651-792 | 59651-0792-0159651-0792-99 | — |
| Haloperidol | Haloperidol 10 mg/1 | TabletOral | 59651-793 | 59651-0793-0159651-0793-99 | — |
| Haloperidol | Haloperidol 20 mg/1 | TabletOral | 59651-794 | 59651-0794-0159651-0794-99 | — |
| Metformin Hydrochloride | Metformin hydrochloride 500 mg/1 | Tablet, Extended releaseOral | 59651-548 | 59651-0548-0159651-0548-0559651-0548-99 | — |
| Metformin Hydrochloride | Metformin hydrochloride 750 mg/1 | Tablet, Extended releaseOral | 59651-549 | 59651-0549-0159651-0549-05 | — |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | Ointment, AugmentedTopical | 59651-699 | 59651-0699-1459651-0699-4659651-0699-50 | — |
| Metformin Hydrochloride | Metformin hydrochloride 850 mg/1 | Tablet, Film coatedOral | 59651-855 | 59651-0855-0159651-0855-0559651-0855-26+5 more | — |
| Desmopressin Acetate | Desmopressin acetate .1 mg/1 | TabletOral | 59651-249 | 59651-0249-01 | — |
| Desmopressin Acetate | Desmopressin acetate .2 mg/1 | TabletOral | 59651-250 | 59651-0250-01 | — |
| Mometasone Furoate Monohydrate | Mometasone furoate monohydrate 50 ug/1 | Spray, MeteredNasal | 59651-402 | 59651-0402-17 | — |
| Sunitinib Malate | Sunitinib malate 12.5 mg/1 | CapsuleOral | 59651-464 | 59651-0464-2859651-0464-29 | — |
| Sunitinib Malate | Sunitinib malate 25 mg/1 | CapsuleOral | 59651-465 | 59651-0465-2859651-0465-29 | — |
| Sunitinib Malate | Sunitinib malate 37.5 mg/1 | CapsuleOral | 59651-466 | 59651-0466-2859651-0466-29 | — |
| Sunitinib Malate | Sunitinib malate 50 mg/1 | CapsuleOral | 59651-467 | 59651-0467-2859651-0467-29 | — |
| Ezetimibe and Simvastatin | Ezetimibe 10 mg/1; Simvastatin 10 mg/1 | TabletOral | 59651-835 | 59651-0835-3059651-0835-90 | — |
| Ezetimibe and Simvastatin | Ezetimibe 10 mg/1; Simvastatin 20 mg/1 | TabletOral | 59651-836 | 59651-0836-3059651-0836-90 | — |
| Ezetimibe and Simvastatin | Ezetimibe 10 mg/1; Simvastatin 40 mg/1 | TabletOral | 59651-837 | 59651-0837-3059651-0837-90 | — |
| Ezetimibe and Simvastatin | Ezetimibe 10 mg/1; Simvastatin 80 mg/1 | TabletOral | 59651-838 | 59651-0838-3059651-0838-90 | — |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | 59651-892 | 59651-0892-0159651-0892-99 | — |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | 59651-893 | 59651-0893-0159651-0893-99 | — |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | 59651-894 | 59651-0894-0159651-0894-99 | — |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | 59651-895 | 59651-0895-0159651-0895-99 | — |
| Fingolimod | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | 65862-952 | 65862-0952-0765862-0952-2865862-0952-30 | — |
| Mycophenolic Acid | Mycophenolate sodium 180 mg/1 | Tablet, Delayed releaseOral | 59651-621 | 59651-0621-08 | — |
| Mycophenolic Acid | Mycophenolate sodium 360 mg/1 | Tablet, Delayed releaseOral | 59651-622 | 59651-0622-08 | — |
| Mycophenolate Mofetil | Mycophenolate mofetil 500 mg/1 | Tablet, Film coatedOral | 59651-638 | 59651-0638-0159651-0638-05 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | 59651-606 | 59651-0606-0559651-0606-3059651-0606-90+1 more | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | 59651-609 | 59651-0609-0559651-0609-3059651-0609-90+1 more | — |
Aurobindo Pharma Limited: common questions
- What is Aurobindo Pharma Limited's NDC labeler code?
- 59651, 84386. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Aurobindo Pharma Limited?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.